-
With the rapid development of pharmaceuticals and new medical procedures, the liability of those involved in patient treatment is becoming a subject of serious discussion. In this newsflash you will find our view of the current situation in our countries, as well as suggestions as to what should be improved and clarified in the interests […]
-
Publication / Marina Golovnitskaya, Yauheni Budchanka, Maksim Salahub, Kaupo Lepasepp, Mirell Prosa, Oliver Kuusk, Rūta Vaicekauskaitė-Jasionė, Paulius Mockevičius, Monika Mališauskaitė-Vaupšienė, Dr Stasys Drazdauskas, Ieva Andersone, Linda Sarāne-Reneslāce, Andris Tauriņš, Jūlija Terjuhana, Private: Gunvaldis Leitens
Our team share another piece of intellectual property (IP) news in the Belarus-Baltics region telling about curious cases, news in legislation, and some measures taken by governments due to the COVID-19 pandemic which may still be helpful to business (mainly extension of statutory deadlines and, in some cases, waiver of statutory duties). IP news from […]
-
Publication / Marina Golovnitskaya, Yauheni Budchanka
Belarus in need of clear telemedicine regulations Currently there is no detailed regulation of telemedicine in Belarus. We are expecting an updated Law on Healthcare, which would address the situation. The key regulatory document providing main areas of the e-health system development is the “Concept of e-health development until 2022”, approved by Order of the […]
-
Publication / Maksim Salahub, Marina Golovnitskaya, Yauheni Budchanka
Puma protects its IP As reported in the local media, in February 2020 Puma became more active in combating counterfeit and parallel imports in Belarus. The first infringer was detained and held to administrative liability for illegal sales of sneakers bearing the Puma trademark. During consideration of the case it was found that the infringer […]
-
Publication / Marina Golovnitskaya, Yauheni Budchanka
Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Belarus specifically targeted at Life Sciences companies. The government has banned export of some medical goods until at least 1 June: respirators, chemical protection suits, bandages, cotton wool, gauze, medical gloves and masks, etc. The Ministry of […]
